- Home
- ALT vs RM Comparison
ALT vs RM Comparison
Compare ALT & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | RM |
|---|---|---|
| Founded | 1997 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 390.4M |
| IPO Year | 2005 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ALT | RM |
|---|---|---|
| Price | $3.21 | $31.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $17.67 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 3.1M | 35.0K |
| Earning Date | 03-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.70% |
| EPS Growth | ★ 25.37 | 7.49 |
| EPS | N/A | ★ 4.45 |
| Revenue | $41,000.00 | ★ $645,598,000.00 |
| Revenue This Year | N/A | $12.78 |
| Revenue Next Year | N/A | $8.78 |
| P/E Ratio | ★ N/A | $7.29 |
| Revenue Growth | ★ 105.00 | 9.70 |
| 52 Week Low | $2.91 | $25.41 |
| 52 Week High | $7.73 | $46.00 |
Technical Indicators
Market Signals| Indicator | ALT | RM |
|---|---|---|
| Relative Strength Index (RSI) | 32.72 | 44.97 |
| Support Level | $2.91 | $30.65 |
| Resistance Level | $4.25 | $35.24 |
| Average True Range (ATR) | 0.18 | 1.06 |
| MACD | -0.02 | 0.25 |
| Stochastic Oscillator | 1.18 | 57.09 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.